LLY stock forecast
Our latest prediction for Eli Lilly & Co.'s stock price was made on the April 9, 2020 when the stock price was at 145.73$.
In the short term (2weeks), LLY's stock price should underperform the market by -1.01%. During that period the price should oscillate between -5.38% and +4.00%.
In the medium term (3months), LLY's stock price should outperform the market by 0.29%. During that period the price should oscillate between -12.40% and +11.62%.
Get email alertsCreate a solid portfolio with LLY
About Eli Lilly & Co.
Eli Lilly & Co. engages in the discovery, development, manufacture and sale of pharmaceutical products. Its products include Forteo, Adrica, BAQSIMI, Basaglar and Glucagn. The company was founded by Eli Lilly on May 1876 and is headquartered in Indianapolis, IN.
At the moment the company generates 22320M USD in revenues.
On its last earning announcement, the company reported a profit of 8.89$ per share.
The book value per share is 10.76$
Three months stock forecastApril 9, 2020
Financials
| Revenue USD | Gross Margin | Operating Income | Operating Margin | Net Income | Earnings Per Share | Dividends | Payout Ratio | Shares | Book Value Per Share | Operating Cash Flow | Cap Spending | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 22320M | 78.80% | 5549M | 24.90% | 8318M | 8.89 | 2.58 | - | 936M | 10.76 | 4837M | -1354M | 3483M |